Companies and organizations that provide diagnostics serve an important role and must overcome many challenges inherent to developing diagnostic solutions. These areas include research and development, the regulatory environment, production and manufacturing, commercialization, and insurance and reimbursement.
The ability to combat the SARS-CoV-2 virus through accelerated advancements in diagnostics, treatment and vaccine development relies on understanding how the virus is transmitted between people and accurately tracking mutations. Whole genome sequencing and subsequent analysis can provide a wealth of data and contribute important insights to this effort.
Unlike bacteria and fungi, viruses exist in a gray area between “living” and “non-living” because of the way they are structured and how they reproduce. As we face down the COVID-19 pandemic, it’s important to understand not only how viruses work, but how our immune system responds.